PDP1 and melanoma: Here, we tested whether the inhibition of this pathway, leading to increased ROS levels, affects PDH phosphorylation as we show ROS-mediated regulation of PDH (Figure 3B’) and it was also reported in melanoma cells (Cesi et al., 2017).